OneSource Specialty Pharma Limited has announced its unaudited financial results for the quarter and six months ended September 30, 2026. For the quarter, the company reported revenue from operations of ₹5,144.96 million and a profit after tax of ₹861.92 million. The six-month period saw revenue from operations reach ₹9,609.67 million with a profit after tax of ₹1,374.17 million.
OneSource Specialty Pharma Announces Q2 FY27 Unaudited Financial Results
OneSource Specialty Pharma Limited has disclosed its unaudited financial results for the quarter and six months ended September 30, 2026. The figures were approved by the Board of Directors on October 27, 2026.
Quarterly Performance (Ended September 30, 2026)
- Revenue from operations: ₹5,144.96 million
- Total income: ₹5,154.19 million
- Profit before tax: ₹861.92 million
- Profit after tax: ₹861.92 million
Six Months Performance (Ended September 30, 2026)
- Revenue from operations: ₹9,609.67 million
- Total income: ₹9,656.77 million
- Profit before tax: ₹1,374.17 million
- Profit after tax: ₹1,374.17 million
The financial statements were reviewed by the statutory auditors, BSR & Co. LLP, who issued an unmodified limited review report.
Additionally, the standalone balance sheet as at September 30, 2026, shows total assets of ₹87,281.58 million and total equity and liabilities of ₹87,281.58 million.
Source: BSE
